BioSpace News Archive

Genetown

Repligen Launches AAV Affinity Resins for Gene Therapy PurificationAVIPure® affinity resins address the market need for high performance and caustic stability

Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the commercial launch of three advanced affinity chromatography resins for use in gene therapy manufacturing workflows.

February 15, 2022

·

4 min read

Business

Mustang Bio Announces City of Hope MB-105 Prostate Stem Cell Antigen CAR T Data Selected for Presentation at the 2022 American Society of Clinical Oncology Genitourinary Cancers Symposium

Mustang Bio, Inc. today announced that City of Hope Phase 1 clinical trial data on MB-105, a prostate stem cell antigen (“PSCA”) chimeric antigen receptor (“CAR”) T-cell therapy administered systemically to patients with PSCA-positive metastatic castration-resistant prostate cancer.

February 15, 2022

·

6 min read

Business

Quipt Home Medical Reports Record First Quarter Fiscal 2022 Financial Results

Quipt Home Medical Corp. today announced its first quarter fiscal 2022 financial results and operational highlights.

February 15, 2022

·

15 min read

Drug Development

TG Therapeutics Announces Data Presentations from the ULTIMATE I & II Phase 3 Trials of Ublituximab in Multiple Sclerosis to be Presented at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum

TG Therapeutics, Inc. today announced the schedule of data presentations highlighting data from the ULTIMATE I & II Phase 3 trials evaluating ublituximab in patients with relapsing forms of multiple sclerosis (RMS).

February 15, 2022

·

8 min read

Business

Opus Genetics Appoints Brian Leising Vice President, Manufacturing

Opus Genetics today announced the appointment of Brian Leising as Vice President of Manufacturing.

February 15, 2022

·

2 min read

Theratechnologies Strengthens Global Commercial Capabilities by Launching Internal Field Force

Theratechnologies Inc., a biopharmaceutical company focused on the development and commercialization of innovative therapies, announced the strengthening of its global commercial capabilities by launching an internal sales force.

February 15, 2022

·

6 min read

Pharm Country

Brainstorm Cell Therapeutics Announces Grant of a New Brazilian Patent Covering Methods of Manufacturing NurOwn®

Brainstorm Cell Therapeutics Inc. today announced that the Brazilian Patent Office has granted the patent application.

February 15, 2022

·

5 min read

Drug Development

Last Patient Completes Treatment in Stealth BioTherapeutics’ Phase 2 Geographic Atrophy Clinical Trial

Stealth BioTherapeutics Corp announced today that the final patient in its 176-subject, ReCLAIM-2 phase 2 clinical trial for extra-foveal geographic atrophy associated with dry age-related macular degeneration (AMD) has completed treatment.

February 15, 2022

·

7 min read

Business

Palatin Reports Second Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update

Palatin Technologies, Inc. today announced results for its fiscal second quarter ended December 31, 2021.

February 15, 2022

·

12 min read

JCR Pharmaceuticals’ Research Presentations at WORLDSymposium™ 2022 Showcase JR-141 (Pabinafusp Alfa) and Other Investigational Treatments for Lysosomal Storage Disorders

JCR Pharmaceuticals’ Research Presentations at WORLD Symposium ™ 2022 Showcase JR-141 (Pabinafusp Alfa) and Other Investigational Treatments for Lysosomal Storage Disorders.

February 15, 2022

·

14 min read